Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-02-05T06:27:42.289Z Has data issue: false hasContentIssue false
  • English
  • Français

X-Ray Diffraction and Fluorescence in the Analysis of Pharmaceutical Excipients

Published online by Cambridge University Press:  06 March 2019

A. J. Durbetaki  and
T. F. Quail
A. J. Durbetaki
Affiliation:
FMC Corporation, Chemical Research and Development Center, Princeton, New Jersey 08540
T. F. Quail
Affiliation:
FMC Corporation, Chemical Research and Development Center, Princeton, New Jersey 08540
Get access

Extract

The majority of pharmaceutical dosage forms are marketed as tablets which are formulated to satisfy various basic requirements. The analysis of the resultant multicomponent pharmaceutical and product is usually a lengthy task.

This paper describes the complementary use of X-ray diffraction (XRD) and X-ray fluorescence spectroscopy (XRS) to characterize and quantify excipients in pharmaceutical tablets.

Type
VIII. XRD Applications
Information
Advances in X-Ray Analysis , Volume 25: Thirtieth Annual Conference on Applications of X-ray Analysis, August 3-7, 1981 , 1981 , pp. 383 - 388
Copyright
Copyright © International Centre for Diffraction Data 1981

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Wakelin, J. H.; Virgin, H. S. and Crystal, E., J. Appl. Phys. 30, 1654 (1959).Google Scholar
2 Criss, J. W.; Birks, L. S. and Gilfrich, J. V., Anal. Chem. 50, 73 (1978).Google Scholar